Skip to main content

Table 4 Changes in out-of-clinic activity (activPAL; min/16 h awake) in the standard clinic (C) and text message-enhanced clinic (EC)

From: Feasibility, acceptability and efficacy of a text message-enhanced clinical exercise rehabilitation intervention for increasing ‘whole-of-day’ activity in people living with and beyond cancer

  

Week 4 (clinic cessation)

Week 12 (text cessation)

Week 12-Week 4

n

M (95%CI)

p

n

M (95%CI)

p

M (95%CI)

p

Sitting (min/16 h awake)

C

18

1.7 (−18.4, 21.8)

0.869

15

−0.5 (−30.2, 29.3)

0.975

−2.2 (−29.9, 25.6)

0.878

EC

18

−14.7 (−34.8, 5.3)

0.151

17

−48.2 (−76.4, − 20.0)

0.001

−33.5 (−59.7, − 7.3)

0.012

EC-C

 

−16.4 (− 46.2, 13.4)

0.281

 

−47.7 (−89.9, − 5.6)

0.023

− 31.3 (−69.5, 6.8)

0.107

Prolonged sitting in ≥20 min bouts (min/16 h awake)

C

18

−8.2 (− 29.7, 13.2)

0.452

15

−8.3 (− 36.7, 20.2)

0.569

0.0 (− 24.8, 24.7)

0.998

EC

18

−16.3 (−37.7, 5.2)

0.137

17

−40.6 (−67.8, − 13.5)

0.003

−24.4 (− 47.7, − 1.1)

0.041

EC-C

 

−8.0 (−39.9, 23.8)

0.622

 

−32.4 (−73.0, 8.3)

0.119

−24.4 (−58.4, 9.6)

0.160

Usual sitting bout duration (min)

C

18

−1.6 (−3.7, 0.5)

0.143

15

−0.1 (−2.6, 2.3)

0.910

1.4 (−1.0, 3.9)

0.247

EC

18

−0.7 (−2.8, 1.4)

0.526

17

−2.8 (−5.1, − 0.4)

0.019

−2.1 (−4.4, 0.2)

0.076

EC-C

 

0.9 (−2.2, 4.0)

0.573

 

−2.6 (−6.2, 0.9)

0.143

−3.5 (− 6.9, −0.2)

0.039

Standing (min/16 h awake)

C

18

−4.4 (−18.4, 9.5)

0.535

15

2.2 (−30.8, 35.3)

0.894

6.7 (−26.4, 39.7)

0.693

EC

18

10.4 (−3.5, 24.4)

0.143

17

44.3 (13.2, 75.4)

0.005

33.9 (2.8, 65.0)

0.033

EC-C

 

14.8 (−6.1, 35.8)

0.164

 

42.1 (−3.9, 88.1)

0.073

27.2 (−18.1, 72.6)

0.239

Stepping (min/16 h awake)

C

18

3.7 (−6.8, 14.3)

0.489

15

−0.5 (−14.1, 13.0)

0.940

−4.2 (−17.8, 9.3)

0.538

EC

18

3.5 (−6.9, 14.0)

0.510

17

2.5 (−10.3, 15.4)

0.698

−1.0 (− 13.8, 11.8)

0.881

EC-C

 

−0.2 (−15.7, 15.3)

0.979

 

3.1 (−16.2, 22.3)

0.756

3.3 (−15.3, 21.9)

0.731

Light stepping (min/16 h awake)

C

18

1.0 (−0.7, 2.7)

0.247

15

0.8 (−4.0, 5.6)

0.749

−0.2 (− 4.6, 4.2)

0.916

EC

18

1.1 (−0.6, 2.9)

0.191

17

7.8 (3.2, 12.3)

0.001

6.6 (2.5, 10.7)

0.002

EC-C

 

0.1 (−2.4, 2.7)

0.921

 

7.0 (0.4, 13.6)

0.039

6.9 (0.8, 12.9)

0.026

Moderate-vigorous stepping (min/16 h awake)

C

18

6.2 (−1.9, 14.3)

0.131

15

−0.4 (−7.3, 6.4)

0.906

−6.6 (− 14.7, 1.4)

0.105

EC

18

1.6 (− 6.3, 9.6)

0.685

17

−3.1 (−9.7, 3.4)

0.345

−4.8 (−12.5, 2.9)

0.222

EC-C

 

−4.6 (−16.4, 7.2)

0.447

 

−2.7 (−12.7, 7.3)

0.593

1.9 (− 9.2, 13.0)

0.743

  1. Table presents mean change over time or mean difference between groups (M) with 95% Confidence Interval (CI) as estimated by mixed models adjusting for baseline values of the outcome, age (years), gender (male/female), time since diagnosis (months) and number of medications currently taken (0/1/≥2). Bold text indicates changes that were significant at p < 0.05
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us